ELAB
PMGC Holdings Inc.
Key Financials
Gross Profit
$185314
↓ 83.7%
Revenue
$590084
↓ 65.5%
Operating Income
$-4414143
N/A
Net Income
$-7747813
↓ 24.0%
Total Assets
$12.9M
↑ 43.1%
EPS (Diluted)
$-0.40
↓ 111.6%
Shareholders' Equity
$7.8M
↑ 17.7%
Total Liabilities
$5.0M
↑ 115.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEF 14A | 5/15/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| PRE 14A | 5/4/2026 | View on SEC |
| DEF 14C | 5/4/2026 | View on SEC |
| 8-K | 4/28/2026 | View on SEC |
| DEF 14C | 4/27/2026 | View on SEC |
| PRE 14C | 4/24/2026 | View on SEC |
| 8-K | 4/23/2026 | View on SEC |
| 8-K | 4/21/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ELAB |
| Company Name | PMGC Holdings Inc. |
| CIK | 1840563 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 888-445-4886 |